Therefore, this study aimed to investigate whether an XO inhibitor could attenuate oxidative stress and protect against DKD by inhibiting VEGF-NADPH oxidase (NOX) signaling pathway in an animal model of DKD and human GECs. Here, VEGFA is linked to diabetic kidney disease.